Frank Dolan is a pioneer in the healthcare innovation space. His accomplishments have been focused on installing highly innovative capabilities at healthcare organizations to advance the speed and impact of modern medicines. At Takeda, Amylin, and Acadia Pharmaceuticals, he was a founding team member responsible for transforming research organizations into fully commercial businesses. Frank’s strong record of increasing company value has resulted in company acquisitions of over $100 billion.  He has founded and advised a portfolio of technology forward companies and products aimed at leveraging emerging technologies to transform big data, media, and operations.